SEC-sourced researchBeta

CLGN

CollPlant Biotechnologies Ltd

US markets

Data passport

CIK: 0001631487
Exchange: Nasdaq
Business activity: — · SIC 3842
Financial inputs: 6/6
Filing date: Oct 6, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

CLGN · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	10,959,000.0000	Mar 26, 2026
December 2024	515,000.0000	Mar 26, 2026
December 2025	2,371,000.0000	Mar 26, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	2,371,000.0000	-11,489,000.0000	-9,419,000.0000	10,785,000.0000	4,704,000.0000	Mar 26, 2026
December 2024	515,000.0000	-16,609,000.0000	-14,093,000.0000	18,710,000.0000	5,245,000.0000	Mar 26, 2026
December 2023	10,959,000.0000	-7,019,000.0000	-2,763,000.0000	—	—	Mar 26, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$2.37M	December 2025	Mar 26, 2026	20-F
Previous period revenueRevenues	$515K	December 2024	Mar 26, 2026	20-F
Net incomeNetIncomeLoss	-$11.49M	December 2025	Mar 26, 2026	20-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$9.42M	December 2025	Mar 26, 2026	20-F
Total assetsAssets	$10.79M	December 2025	Mar 26, 2026	20-F
Total liabilitiesLiabilities	$4.7M	December 2025	Mar 26, 2026	20-F

New filings

Explore methodology ↗